Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (Peripheral blood S100 mRNAs and metabolic syndrome).

[1]  T. Funahashi,et al.  A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells , 2012, PloS one.

[2]  T. Funahashi,et al.  High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density. , 2012, Diabetes research and clinical practice.

[3]  T. Funahashi,et al.  High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. , 2012, Biochemical and biophysical research communications.

[4]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[5]  S. Kihara,et al.  Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-&ggr; Agonist Rivoglitazone , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[6]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[7]  Gene Kim,et al.  Vascular Remodeling and Arterial Calcification Are Directly Mediated by S100A12 (EN-RAGE) in Chronic Kidney Disease , 2011, American Journal of Nephrology.

[8]  T. Funahashi,et al.  One-Year Reductions in Body Weight and Blood Pressure, but Not in Visceral Fat Accumulation and Adiponectin, Improve Urinary Albumin-to-Creatinine Ratio in Middle-Aged Japanese Men , 2010, Diabetes Care.

[9]  K. Croce.  S100A8/A9 Complex , 2010 .

[10]  A. Bahl,et al.  Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. , 2009, Atherosclerosis.

[11]  B. Pedersen,et al.  Calprotectin — A Novel Marker of Obesity , 2009, PloS one.

[12]  M. Raftery,et al.  Oxidative modifications of S100 proteins: functional regulation by redox , 2009, Journal of leukocyte biology.

[13]  C. Heizmann,et al.  Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.

[14]  Y. Mori,et al.  Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis , 2008, American Journal of Nephrology.

[15]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[16]  E. Ferrannini,et al.  Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  P. Libby,et al.  Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.

[18]  Kunihiko Kobayashi,et al.  Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease , 2005, European Journal of Pediatrics.

[19]  Makoto Nishida,et al.  A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.

[20]  Y. Mori,et al.  Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[21]  J. Flier.  Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.

[22]  J. Fernández-Real,et al.  Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss , 2011, Molecular medicine.

[23]  P. Libby,et al.  Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. , 2008, American heart journal.

[24]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.